October 24, 2015 Cincinnati, Ohio

Symposium Director

Henry A. Nasrallah, MD
The Sydney W. Souers Professor and Chair
Department of Neurology and Psychiatry
Saint Louis University School of Medicine
St. Louis, Missouri
Dr. Henry Nasrallah is professor and chairman of the Department of Neurology and Psychiatry at Saint Louis University, and holds the Sydney W. Souers Endowed Chair. He is a widely recognized neuropsychiatrist, educator and researcher. Following his psychiatric residency at the University of Rochester and neuroscience fellowship at the NIH, he served as chair of the Ohio State University Department of Psychiatry for twelve years. In January 2003, he joined the University of Cincinnati College of Medicine as Associate Dean and Professor of Psychiatry and Neuroscience. In October 2013, he joined St. Louis University to chair the integrated Department of Neurology and Psychiatry.
Dr. Nasrallah's research focuses on the neurobiology and psychopharmacology of schizophrenia and related psychoses. He has published 380 scientific articles, 440 abstracts, as well as 11 books. He is Editor-In-Chief of two journals (SCHIZOPHRENIA RESEARCH and CURRENT PSYCHIATRY) and is the co-founder of the Schizophrenia International Research Society (SIRS). He is board certified in in adult psychiatry. He is a fellow in the American College of Neurpsychopharmacology (ACNP) a distinguished fellow of the American Psychiatric Association (APA) , and has served as president of the Cincinnati Psychiatric Society and as president of the American Academy of Clinical Psychiatrists. He has twice received the NAMI Exemplary Psychiatrist Award and was chosen as the U.S.A. Teacher of the Year by the Psychiatric Times. He has received over 90 research grants and is listed in all editions of the book "Best Doctors in America".

2015 Faculty

Leslie Citrome, MD
Clinical Professor of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, NY
Leslie Citrome, MD, MPH, is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, New York and has a private practice in Pomona, New York. He is a member of the Board of Directors of the American Society of Clinical Psychopharmacology and the Mental Health Association of Rockland County. Dr Citrome was the Founding Director of the Clinical Research and Evaluation Facility at the Nathan S Kline Institute for Psychiatric Research in Orangeburg, New York, and after nearly 2 decades of government service as a researcher in the psychopharmacological treatment of severe mental disorders, Dr Citrome is now engaged as a consultant in clinical trial design and interpretation. He is a frequent lecturer on the quantitative assessment of clinical trial results using evidence-based medicine. Dr Citrome graduated from the McGill University Faculty of Medicine and completed a residency and chief residency in psychiatry at New York University. His primary research interests have centered on psychopharmacologic approaches to schizophrenia, bipolar disorder, major depressive disorder, the management of treatment-refractory schizophrenia, and the management of aggressive and violent behavior. Dr Citrome has authored or coauthored more than 400 research reports, reviews, chapters, and abstracts in the scientific literature. He serves as Editor-in-Chief for the International Journal of Clinical Practice and is on the editorial board of 9 other medical journals. He has lectured extensively throughout the United States, Canada, Europe, and Asia. Dr Citrome is the author of the book, Handbook of Treatment-Resistant Schizophrenia, published in 2013 by Springer Healthcare.
Jason I. Dailey, MD, FAPA*
Medical Corps, US Army
Commander, 212th Medical Detachment (COSC)
Fort Campbell, KY
Jan Fawcett, MD*
Professor of Psychiatry
University of New Mexico
Albuquerque, NM
Dr. Fawcett, a graduate of Yale University School of Medicine, joined the Department of Psychiatry of the University of New Mexico School of Medicine, after thirty years of service as the Stanley Harris, Sr. Chairman of the Department of Psychiatry at Rush Medical College in Chicago.

Dr. Fawcett has pursued a career of research in the treatment of affective disorders and the prevention of suicide since completing his fellowship at the National Institute of Mental Health Clinical Center in 1964. Dr Fawcett has been awarded the Dr. Jan Fawcett Humanitarian Award by the National Depressive and Manic Depressive Association (now the Depression and Bipolar Support Alliance), and lifetime research awards by the American Association of Suicidology and the American Foundation for Suicide Prevention. He was also presented the Menninger award by the American College of Physicians for his research in mental health in 2000.

In 2005, Dr Fawcett shared the Falcone Prize for affective disorders research from the National Alliance for Research in Schizophrenia and Depression (NARSAD). He is currently a principal investigator of the "Recurrent Depression Prevention with Medication and Cognitive Behavioral Therapy" project, a five year study funded by NIMH at Rush Medical Center in collaboration with investigators at Vanderbilt and the University of Pennsylvania. He is a co-author of the APA Practice Guidelines on the assessment and management of suicidal patients and is the chairperson of the DSM-5 Mood Disorders Task Force from 2007-2012.

Dr. Fawcett has always maintained an active clinical practice focusing on patients with treatment-resistant major affective disorders and continues to do so in his work as a Professor at the University of New Mexico School of Medicine, Department of Psychiatry.
Marlene Freeman, MD
Associate Professor of Psychiatry, Harvard Medical School
Medical Director, CTNI
Director of Clinical Services, Perinatal and Reproductive
Psychiatry Program
Massachusetts General Hospital
Marlene P. Freeman, MD is an Associate Professor of Psychiatry, Harvard Medical School.

She is the Director of Clinical Services, Perinatal and Reproductive Psychiatry Program at Massachusetts General Hospital and the Medical Director of the MGH Clinical Trials Network and Institute.

Dr. Freeman completed medical school at Northwestern University Medical School. She completed residency at the Harvard Longwood Psychiatry Residency Program and a research fellowship in the Biological Psychiatry Program at the University of Cincinnati College of Medicine. Her research and clinical expertise is in the areas of mood disorders and women's mental health. She previously established and directed Women's Mental Health Programs at the University of Arizona and the University of Texas Southwestern Medical Center. She is the Director of Clinical Services at the MGH Center for Women's Mental Health, Perinatal and Reproductive Psychiatry. She is Vice Editor-in-Chief for The Journal of Clinical Psychiatry. She is a Distinguished Fellow of the American Psychiatric Association (APA), and chaired the APA Task Force on Complementary and Alternative Medicine, subcommittee on Omega-3 Fatty Acids in Psychiatry, and was a member of the APA's workgroup on Major Depressive Disorder treatment guidelines. She is on the Board of Directors of the American Society of Clinical Psychopharmacology (ASCP) and Postpartum Progress, Inc., and is a Member of the American College of Neuropsychopharmacology (ACNP). She is a Member of the Veterans Administration Reproductive Mental Health Steering Committee.
Jeffrey Strawn, MD
Assistant Professor of Psychiatry
Department of Psychiatry & Behavioral Neuroscience
University of Cincinnati
Cincinnati, OH
Jeffrey R. Strawn, MD, FAACAP, is Assistant Professor of Psychiatry and Pediatrics at the University of Cincinnati and Cincinnati Children's Hospital Medical Center. Originally from Kentucky, Dr. Strawn earned a bachelor's degree in biology from the University of Kentucky and went on to earn his M.D. from the University of Cincinnati, College of Medicine. He completed his psychiatric residency training at UC and a clinical fellowship in child and adolescent psychiatry at Cincinnati Children's. He has board certification in general, as well as child and adolescent, psychiatry.
Rajiv Tandon, MD
Chief of Psychiatry
Program of Mental Health
State of Florida Department of Children and Families
Gainesville, FL
Rajiv Tandon, MD, is the Chief of Psychiatry in the Program of Mental Health at the State of Florida Department of Children and Families. Formerly, he was promoted to Associate Professor, given Tenure and rose to Professor at the Department of Psychiatry in the University of Michigan Medical Center, Ann Arbor, from 1987-2004. In addition to his medical degree, he has a Master's degree in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health and a diploma in Business Administration from the Harvard University Business School. At the University of Michigan, he developed the clinical and research Schizophrenia Program, which was the sixth most published schizophrenia program in the world in the 1990's.

Additionally, he held a variety of administrative responsibilities, including directing the Hospital Services Division (inpatient, consultation-liaison, and emergency psychiatry) and Division of Community Psychiatry from 1996-2000. From 1993-1996, he was the Director of the Adult Inpatient Psychiatry Program and the electroconvulsive Therapy (ECT) Program. At the University of Michigan Medical Center, his clinical responsibilities were primarily on the adult inpatient unit, which he directed from 1993-1996. His research focus has been the psychopathology and neurobiology of schizophrenia. Since 2000, he has been a member of the Scientific Council of the National Alliance for the Mentally Ill and on the Board of Directors of the National Schizophrenia Foundation (Chair 2002-2005).

Dr. Tandon has authored more than 250 scientific publications, and given over 600 national and international scientific presentations. He has received several awards for research and teaching in schizophrenia, including the American Psychiatric Association Young Psychiatrist Researcher of the Year award in 1993 and the a1997 Future Psych award for outstanding achievement in schizophrenia research. He has been included in every edition of THE BEST DOCTORS IN AMERICA since 1995. His principal areas of research interest include psychopharmacology of schizophrenia and neurobiology of schizophrenia. He is a member of the NASMHPD Medical Directors' Board, a member of the World Psychiatric Association Section on Pharmacopsychiatry, and a member of the DSM-V workgroup on psychotic disorders. He is also a member of the editorial boards of several journals. He has been a member of several NIH study sections over his career.

In his capacity Chief of Psychiatry in the Office of Mental Health in the Department of Children and Families, he has participated in the development of a number of innovative programs. He was a member of the Blueprint Commission on Juvenile Justice as also a member of the Supreme Court Subcommittee on Criminal Justice and Mental Health (Leifman committee). He has been intimately involved in the development of a range of evidence-based psychopharmacology programs both in the hospital-based and community settings. He has over 25 years of experience in the evaluation and treatment of psychiatric patients, as national expert, researcher, and mentor.